Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2006 | 09-2005 | 09-2004 | 09-2003 | 09-2002 | |
| Sales | 92 | 252 | 305 | 0 | 0 |
| Gross Profit | 92 | 252 | 305 | N/A | N/A |
| Operating Expenses | 5,696 | 7,189 | 12,282 | 4,805 | 6,705 |
| Operating Income | -5,604 | -6,937 | -11,977 | -4,805 | -6,705 |
| Interest Expense | 89 | 0 | 5,213 | 192 | 50 |
| Other Income | -35 | 32 | 23 | 147 | -890 |
| Pre-tax Income | -5,728 | -6,905 | -17,167 | -4,850 | -7,645 |
| Net Income Continuous | -5,728 | -6,905 | -17,167 | -4,850 | -7,645 |
| Net Income Discontinuous | N/A | N/A | N/A | 1,874 | -3,657 |
| Net Income | $-5,728 | $-6,905 | $-17,167 | $-2,976 | $-11,302 |
| EPS Basic Total Ops | -0.31 | -0.49 | -2.06 | -2.88 | -9.40 |
| EPS Basic Continuous Ops | -0.30 | -0.49 | -2.05 | -4.25 | -6.58 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 1.37 | -2.82 |
| EPS Diluted Total Ops | -0.31 | -0.49 | -2.06 | -2.88 | -9.40 |
| EPS Diluted Continuous Ops | -0.30 | -0.49 | -2.05 | -4.25 | -6.58 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 1.37 | -2.82 |
| EBITDA(a) | $-5,604 | $-6,928 | $-11,952 | $-4,645 | $-6,324 |